ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Summary: IDH Mutated Cholangiocarcinoma - Diagnostic and T…

2024 ESMO Annual Meeting Insights Hub

T. Macarulla Mercade

Management of Hepatocellular Carcinoma & Cholangiocarcinoma - Role o…

Houston Methodist

A. O. Kaseb

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

Flavio Rocha

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

Insights from 2023 ESMO Annual Meeting

L. Rimassa

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

Arndt Vogel

Evolving Epidemiology of Hepatocellular Cancer & Cholangiocarcinoma

Houston Methodist

A. Connor

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -03 Cl…

Insights from 2023 ESMO Annual Meeting

A. Lamarca

ESMO 2023 Insights: "Tinengotinib in Pts With Advanced, FGFR Inhibit…

Insights from 2023 ESMO Annual Meeting

M. Pelster

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Penn Medicine Abramson Cancer Center

T. Karasic

Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Curre…

Houston Methodist

A. Connor, A. O. Kaseb, S. Kodali

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Class?"

Insights from 2023 ASCO® Annual Meeting

A. Vogel

The Importance of Proactive Management of AEs Associated with FGFR2i…

Angelo Pirozzi

Year in Review: Hepato-Biliary Surgical Oncology

OncoAlert

S. Conci

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing…

UChicago Medicine

A. A. Pillai

Cholangiocarcinoma Updates

Houston Methodist

M. Javle

The Role of Liver Transplantation in Cholangiocarcinoma

Stanford Medicine

T. Tara Ghaziani

Treatment Algorithm Series: Management of Advanced Cholangiocarcinoma

Richard Kim

A. Mahipal

Cholangiocarcinoma: Disease Overview, Diagnosis, and Treatment Optio…

MedNews Week

J. Cleary

Immunotherapy for Cholangiocarcinoma

Nicola Personeni